Literature DB >> 7731687

Two serum response elements mediate transcriptional repression of human smooth muscle alpha-actin promoter in ras-transformed cells.

P Bushel1, J H Kim, W Chang, J J Catino, H E Ruley, C C Kumar.   

Abstract

The mechanism by which activated ras oncogene expression leads to repression of genes encoding specific actin filament proteins is not understood. However, these changes associated with loss of organized actin filaments, are necessary to maintain the transformed phenotype. The human smooth muscle (sm) alpha-actin promoter is repressed in ras-transformed fibroblast cells and derepressed in revertant cell lines. In this study, we demonstrate that two serum response elements (SREs) present in the alpha-actin promoter are required for transcriptional repression in ras-transformed cells and the two SREs act synergistically to repress heterologous promoters in a ras-transformation dependent manner. Serum response factor (SRF), which can bind to the sm alpha-actin SREs, restores alpha-actin promoter activity in ras-transformed cells. c-Fos, c-Jun and YY1 also repress alpha-actin promoter through SREs, suggesting that these transcription factors may play a role in repressing alpha-actin promoter in ras-transformed cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7731687

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  AP-1 differentially expressed proteins Krp1 and fibronectin cooperatively enhance Rho-ROCK-independent mesenchymal invasion by altering the function, localization, and activity of nondifferentially expressed proteins.

Authors:  Heather J Spence; Lynn McGarry; Catherine S Chew; Neil O Carragher; Linda A Scott-Carragher; Zhengqiang Yuan; Daniel R Croft; Michael F Olson; Margaret Frame; Bradford W Ozanne
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

Review 2.  Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation.

Authors:  K Sobue; K Hayashi; W Nishida
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

3.  Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells.

Authors:  Masahiro Takakura; Satoru Kyo; Masaki Inoue; Woodring E Wright; Jerry W Shay
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

4.  Yin yang 1 is a novel regulator of pulmonary fibrosis.

Authors:  Xin Lin; Patricia J Sime; Haodong Xu; Marc A Williams; Larry LaRussa; Steve N Georas; Jia Guo
Journal:  Am J Respir Crit Care Med       Date:  2010-12-17       Impact factor: 21.405

5.  Control of cell cycle progression by c-Jun is p53 dependent.

Authors:  M Schreiber; A Kolbus; F Piu; A Szabowski; U Möhle-Steinlein; J Tian; M Karin; P Angel; E F Wagner
Journal:  Genes Dev       Date:  1999-03-01       Impact factor: 11.361

6.  Cytoplasmic YY1 is associated with increased smooth muscle-specific gene expression: implications for neonatal pulmonary hypertension.

Authors:  Laure Favot; Susan M Hall; Sheila G Haworth; Paul R Kemp
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

7.  Increased actin polymerization reduces the inhibition of serum response factor activity by Yin Yang 1.

Authors:  Peter D Ellis; Karen M Martin; Colin Rickman; James C Metcalfe; Paul R Kemp
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

8.  Genetic variation of the human α-2-Heremans-Schmid glycoprotein (AHSG) gene associated with the risk of SARS-CoV infection.

Authors:  Xiaohui Zhu; Yan Wang; Hongxing Zhang; Xuan Liu; Ting Chen; Ruifu Yang; Yuling Shi; Wuchun Cao; Ping Li; Qingjun Ma; Yun Zhai; Fuchu He; Gangqiao Zhou; Cheng Cao
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

9.  Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.

Authors:  Hassan Afif; Mohamed Benderdour; Leandra Mfuna-Endam; Johanne Martel-Pelletier; Jean-Pierre Pelletier; Nicholas Duval; Hassan Fahmi
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.